Azure Biosystems

Portfolio Asset

Name Azure Biosystems
Type Operating Company


Azure Biosystems manufactures and sells imaging systems and reagents for life science researchers. The company is led by its founder, largest investor and third-time CEO who has a range of experiences. The team’s approach to the market is to identify heavily used products and workflows that feature old technology (usually instrument platforms). Then they enter the market with a much-improved product that quickly gains share before the incumbent has a chance to respond. This strategy has been successful and led them to over $10 million in revenues the last few years.